Literature DB >> 15827138

Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses.

Karl-Klaus Conzelmann1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15827138      PMCID： PMC1082782          DOI： 10.1128/JVI.79.9.5241-5248.2005

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  97 in total

Review 1.  Immunotherapeutic uses of CpG oligodeoxynucleotides.

Authors:  Dennis M Klinman
Journal:  Nat Rev Immunol       Date:  2004-04       Impact factor: 53.106

2.  Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene.

Authors:  M Sato; N Tanaka; N Hata; E Oda; T Taniguchi
Journal:  FEBS Lett       Date:  1998-03-20       Impact factor: 4.124

3.  Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

Authors:  M Yoneyama; W Suhara; Y Fukuhara; M Fukuda; E Nishida; T Fujita
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

4.  Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.

Authors:  R Lin; C Heylbroeck; P M Pitha; J Hiscott
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

5.  Interferon regulatory factor 3 and CREB-binding protein/p300 are subunits of double-stranded RNA-activated transcription factor DRAF1.

Authors:  B K Weaver; K P Kumar; N C Reich
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

Review 6.  Measles: immune suppression and immune responses.

Authors:  William J Moss; Martin O Ota; Diane E Griffin
Journal:  Int J Biochem Cell Biol       Date:  2004-08       Impact factor: 5.085

7.  Specific inhibition of type I interferon signal transduction by respiratory syncytial virus.

Authors:  Murali Ramaswamy; Lei Shi; Martha M Monick; Gary W Hunninghake; Dwight C Look
Journal:  Am J Respir Cell Mol Biol       Date:  2004-01-12       Impact factor: 6.914

Review 8.  Vesicular stomatitis virus: re-inventing the bullet.

Authors:  Brian D Lichty; Anthony T Power; David F Stojdl; John C Bell
Journal:  Trends Mol Med       Date:  2004-05       Impact factor: 11.951

9.  Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages [corrected].

Authors:  Kirsten M Spann; Kim-C Tran; Bo Chi; Ronald L Rabin; Peter L Collins
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Recognition of single-stranded RNA viruses by Toll-like receptor 7.

Authors:  Jennifer M Lund; Lena Alexopoulou; Ayuko Sato; Margaret Karow; Niels C Adams; Nicholas W Gale; Akiko Iwasaki; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-19       Impact factor: 11.205
View more
  59 in total

1.  The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses.

Authors:  Peter J Alff; Irina N Gavrilovskaya; Elena Gorbunova; Karen Endriss; Yuson Chong; Erika Geimonen; Nandini Sen; Nancy C Reich; Erich R Mackow
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Interferon-induced alterations in the pattern of parainfluenza virus 5 transcription and protein synthesis and the induction of virus inclusion bodies.

Authors:  T S Carlos; R Fearns; R E Randall
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Interfering with interferons: Hepatitis C virus counters innate immunity.

Authors:  Eric C Freundt; Michael J Lenardo
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-28       Impact factor: 11.205

4.  Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases.

Authors:  Alan C Jackson; John P Rossiter; Monique Lafon
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

Review 5.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

6.  Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.

Authors:  Farooq Nasar; Demetrius Matassov; Robert L Seymour; Theresa Latham; Rodion V Gorchakov; Rebecca M Nowak; Grace Leal; Stefan Hamm; John H Eldridge; Robert B Tesh; David K Clarke; Scott C Weaver
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

7.  The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response.

Authors:  Teresa de Los Santos; Sonia de Avila Botton; Rudi Weiblen; Marvin J Grubman
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

8.  Peripheral, but not central nervous system, type I interferon expression in mice in response to intranasal vesicular stomatitis virus infection.

Authors:  Mark D Trottier; Douglas S Lyles; Carol Shoshkes Reiss
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

9.  Up-regulation of chemokine gene transcripts and T-cell infiltration into the central nervous system and dorsal root ganglia are characteristics of experimental European bat lyssavirus type 2 infection of mice.

Authors:  K L Mansfield; N Johnson; A Nunez; D Hicks; A C Jackson; A R Fooks
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

10.  A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function.

Authors:  Teresa de los Santos; Fayna Diaz-San Segundo; James Zhu; Marla Koster; Camila C A Dias; Marvin J Grubman
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.